Works matching IS 00221899 AND DT 2006 AND VI 194 AND IP 12


Results: 39
    2
    3
    4
    5
    6
    7

    REVIEWERS.

    Published in:
    Journal of Infectious Diseases, 2006, v. 194, n. 12, p. 1801, doi. 10.1086/510691
    Publication type:
    Article
    8

    ERRATUM.

    Published in:
    2006
    Publication type:
    Correction Notice
    9

    ERRATUM.

    Published in:
    2006
    Publication type:
    Correction Notice
    10
    11

    Reply to Achour et al.

    Published in:
    2006
    By:
    • Ogata, Masao;
    • Satou, Takako;
    • Kawano, Rie;
    • Kikuchi, Hiroshi;
    • Kadota, Jun-Ichi
    Publication type:
    Letter
    12
    13

    Reply to Gargiullo et al.

    Published in:
    2006
    By:
    • Rothman, Kenneth J.;
    • Arellano, Felix M.;
    • Yinong Young-Xu;
    • Simonsen, Lone
    Publication type:
    Letter
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV-1 Candidate Vaccine Delivered by a Replication-Defective Recombinant Adenovirus Vector.

    Published in:
    Journal of Infectious Diseases, 2006, v. 194, n. 12, p. 1638
    By:
    • Catanzaro, Andrew T.;
    • Koup, Richard A.;
    • Roederer, Mario;
    • Bailer, Robert T.;
    • Enama, Mary E.;
    • Moodie, Zoe;
    • Lin Gu;
    • Martin, Julie E.;
    • Novik, Laura;
    • Chakrabarti, Bimal K.;
    • Butman, Bryan T.;
    • Gall, Jason G. D.;
    • King, C. Richter;
    • Andrews, Charla A.;
    • Sheets, Rebecca;
    • Gomez, Phillip L.;
    • Mascola, John R.;
    • Nabel, Gary J.;
    • Graham, Barney S.
    Publication type:
    Article
    31
    32
    33
    34
    35
    36

    Cyclosporin A Provides No Sustained Immunologic Benefit to Persons with Chronic HIV-1 Infection Starting Suppressive Antiretroviral Therapy: Results of a Randomized, Controlled Trial of the AIDS Clinical Trials Group A5138.

    Published in:
    Journal of Infectious Diseases, 2006, v. 194, n. 12, p. 1677, doi. 10.1086/509261
    By:
    • Lederman, Michael M.;
    • Smeaton, Laura;
    • Smith, Kim Y.;
    • Rodriguez, Benigno;
    • Minya Pu;
    • Hongying Wang;
    • Sevin, Anne;
    • Tebas, Pablo;
    • Sieg, Scott F.;
    • Medvik, Kathy;
    • Margolis, David M.;
    • Pollard, Richard;
    • Ertl, Hildegund C. J.;
    • Valdez, Hernan
    Publication type:
    Article
    37

    A Randomized, Partially Blinded Phase 2 Trial of Antiretroviral Therapy, HIV-Specific Immunizations, and Interleukin-2 Cycles to Promote Efficient Control of Viral Replication (ACTG A5024).

    Published in:
    Journal of Infectious Diseases, 2006, v. 194, n. 12, p. 1672
    By:
    • Kilby, J. Michael;
    • Bucy, R. Pat;
    • Mildvan, Donna;
    • Fischl, Margaret;
    • Santana-Bagur, Jorge;
    • Lennox, Jeff;
    • Pilcher, Chris;
    • Zolopa, Andrew;
    • Lawrence, Jody;
    • Pollard, Richard B.;
    • El Habib, Raphaelle;
    • Sahner, David;
    • Fox, Lawrence;
    • Aga, Evgenia;
    • Bosch, Ronald J.;
    • Mitsuyasu, Ronald
    Publication type:
    Article
    38
    39